OpenAI IPO Delay, Anthropic's Mythos 5 Cleared Amidst US Government Scrutiny

The landscape for leading AI developers, OpenAI and Anthropic, is increasingly being shaped by the intervention of the U.S. government, impacting both their market strategies and product releases. OpenAI is reportedly considering pushing back its initial public offering (IPO) to 2027, a shift from earlier plans that saw the company file a confidential S-1 prospectus. This potential delay comes as the company works with the government on a staggered release of its new GPT-5.6 models, including the flagship GPT-5.6 Sol, due to cybersecurity concerns. Concurrently, Anthropic, a direct competitor, has seen its advanced AI model, Mythos 5, cleared for limited deployment. This decision by the U.S. Commerce Department allows approximately 100 vetted U.S. organizations, primarily those involved in defending critical infrastructure, to access the powerful cybersecurity model. This clearance follows a period where both Mythos 5 and its counterpart, Fable 5, were temporarily suspended at the government's request, reflecting a broader effort to vet AI products for potential national security risks. The government's involvement underscores a significant trend where regulatory bodies are asserting greater control over the development and distribution of cutting-edge AI. Both companies have been in discussions with U.S. officials, including Commerce Secretary Howard Lutnick, to address concerns regarding the capabilities and potential misuse of these powerful models. OpenAI, while viewing the current testing period as temporary, has acknowledged the need for a phased approach to broader availability. Anthropic's journey with its 'o-series' models, Fable 5 and Mythos 5, has been particularly contentious, including a lawsuit against the government over initial restrictions. The partial lifting of the ban on Mythos 5 is seen as a positive step, with Anthropic expressing a commitment to continue working with the government to expand access and potentially reintroduce Fable 5. This regulatory oversight is becoming a defining factor for AI companies, influencing not only their product roadmaps but also their market valuations and public debut timelines, as they navigate the complex interplay between innovation and national security.